Deals

Pressure BioSciences Raises $1.4M in Conv Preferred Deal

By |

Pressure BioSciences, Inc. (PBIO) announced that it has raised $1,398,044 in a Convertible Preferred Stock transaction. The fixed conversion price of the Convertible Preferred Stock is $0.25 per share, an approximate 7.41% discount to the market price ($0.27) of PBIO at deal announcement. A series of 2,796,000 36-Month Warrants with an exercise price of $0.31 per share (15.74% premium) was issued to the investors in this transaction. Issuer counsel was Szaferman Lakind Blumstein & Blader, PC. This Placement funded in tranches.

Deals

Idera Pharmaceuticals Closes $36M CMPO Priced near Market via Cowen, Piper Jaffray

By |

Idera Pharmaceuticals, Inc. (IDRA) announced that it has raised $36,000,000 in a CMPO/Overnight transaction. The common stock was sold at $4.00 per share, an approximate 4% discount to the market price ($4.17) of IDRA at deal announcement. Cowen and Company and Piper Jaffray acted as Book-Runners on the transaction. Underwriter counsel was Dechert, LLP and issuer counsel was Wilmer Cutler Pickering Hale & Dorr, LLP . The transaction is expected to close by 02/10/2014.

Deals

Agenus Closes $52M CMPO via William Blair-led Group

By |

Agenus, Inc. (AGEN) announced that it has raised $52,206,263 in a CMPO/Overnight transaction. The common stock was sold at $2.70 per share, an approximate 7% discount to the market price ($2.90) of AGEN at deal announcement. William Blair acted as Sole Book-Runner with Maxim Group as Lead Manager and H.C. Wainwright and MLV as Co-Managers and Geller Biopharm as Financial Advisor on the transaction. Underwriter counsel was Morrison & Foerster and issuer counsel was Choate, Hall & Stewart. This Placement is subject to customary closing conditions and is expected to close by 02/10/2014.

Deals

Skyline Medical Raises $2M in Conv Preferred Deal from Insiders

By |

Skyline Medical Inc. (SKLN) announced that it has raised $2,055,000 in a Convertible Preferred Stock transaction. The fixed conversion price of the Convertible Preferred Stock is $0.26 per share, an approximate 8.33% premium to the market price ($0.24) of SKLN at deal announcement. A series of 1,600,000 60-Month Warrants with an exercise price of $0.33 per share (35.42% premium) was issued to the investors in this transaction. The Investors include the Company's CEO. Issuer counsel was Reed Smith.